VTv Therapeutics shares surge 40 percent
April 17, 2018 at 14:43 PM EDT
It's the first day the stock hit above $1 since vTv Therapeutics reported disappointing results from the Phase 3 study of its drug azeliragon.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.